Page last updated: 2024-11-07

aldosterone and Breast Neoplasms

aldosterone has been researched along with Breast Neoplasms in 42 studies

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research Excerpts

ExcerptRelevanceReference
"To elucidate the combined effects of fadrozole (nonsteroidal aromatase inhibitor) and tamoxifen, 11 postmenopausal patients with recurrent breast cancer were examined between October 1996 and June 1998."9.09[A combined effect of fadrozole and tamoxifen in postmenopausal patients with recurrent breast cancer: a preliminary report: Japanese Cooperative Study Group of Fadrozole and Tamoxifen]. ( Kimura, M; Nomura, Y; Ohashi, Y; Takashima, S; Toge, T; Tominaga, T, 2000)
"This Phase II study was designed to determine the efficacy and tolerability of vorozole (R83842), a new nonsteroidal aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression being treated with tamoxifen, and to correlate these effects with the hormonal profile and plasma drug levels."9.08Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen. ( Ambus, U; Bruynseels, J; Clark, RM; Crump, M; De Coster, R; Goss, PE; Tye, LM; Wadden, NA; Walde, D; Weizel, HA, 1995)
"Aminoglutethimide (Ag) is a potent aromatase-enzyme inhibitor used in the treatment of patients with breast cancer."9.07Adrenal effects of low-dose aminoglutethimide when used alone in postmenopausal women with advanced breast cancer. ( Carella, MJ; Dimitrov, NV; Gossain, VV; Rovner, DR; Srivastava, L, 1994)
"The aim of this study is to report on Aminoglutethimide-induced hormonal modifications in advanced breast cancer."7.67Preliminary study of hormone determinations during aminoglutethimide therapy for advanced breast cancer. ( Díaz, L; Koliren, L; Loruso, A; Ramos, G; Scaglia, HE; Soto, E; Zylbersztein, C, 1984)
"Thirteen of 15 patients with malignant ascites achieved an excellent response to spironolactone, with an increase in urinary sodium excretion rates from less than 35 mEq/d before treatment to between 50 and 245 mEq/d after treatment."7.66Control of malignant ascites with spironolactone. ( Greenway, B; Johnson, PJ; Williams, R, 1982)
"Letrozole appears to be a very promising new antiaromatase drug."6.68Letrozole, a new oral non-steroidal aromastase inhibitor in treating postmenopausal patients with advanced breast cancer. A pilot study. ( Bisagni, G; Cocconi, G; Fraschini, F; Pfister, C; Scaglione, F; Trunet, PF, 1996)
" While this regimen effectively blocked adrenal function, it was complicated by a drug interaction in which aminoglutethimide accelerated the metabolism and reduced the bioavailability of dexamethasone."6.36Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer. ( Harvey, H; Kendall, J; Lipton, A; Ruby, EB; Samojlik, E; Santen, RJ; Wells, SA, 1977)
"To elucidate the combined effects of fadrozole (nonsteroidal aromatase inhibitor) and tamoxifen, 11 postmenopausal patients with recurrent breast cancer were examined between October 1996 and June 1998."5.09[A combined effect of fadrozole and tamoxifen in postmenopausal patients with recurrent breast cancer: a preliminary report: Japanese Cooperative Study Group of Fadrozole and Tamoxifen]. ( Kimura, M; Nomura, Y; Ohashi, Y; Takashima, S; Toge, T; Tominaga, T, 2000)
"This Phase II study was designed to determine the efficacy and tolerability of vorozole (R83842), a new nonsteroidal aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression being treated with tamoxifen, and to correlate these effects with the hormonal profile and plasma drug levels."5.08Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen. ( Ambus, U; Bruynseels, J; Clark, RM; Crump, M; De Coster, R; Goss, PE; Tye, LM; Wadden, NA; Walde, D; Weizel, HA, 1995)
"Aminoglutethimide (Ag) is a potent aromatase-enzyme inhibitor used in the treatment of patients with breast cancer."5.07Adrenal effects of low-dose aminoglutethimide when used alone in postmenopausal women with advanced breast cancer. ( Carella, MJ; Dimitrov, NV; Gossain, VV; Rovner, DR; Srivastava, L, 1994)
"Both medroxyprogesterone acetate (MPA) and megestrol acetate (MA) are effective in the treatment of metastatic breast cancer."5.05[Megestrol acetate in various doses in the treatment of metastatic breast carcinoma--clinical and endocrinologic studies]. ( Blossey, HC; Emrich, D; Nagel, GA; Wander, HE, 1985)
"Long term treatment of breast cancer patients with 10 mg/day has continued in 17 patients without an escape of estradiol suppression."3.78ARIMIDEX: a new oral, once-a-day aromatase inhibitor. ( Demers, L; Dowsett, M; Dyroff, M; Plourde, PV; Webster, A; Yates, R, 1995)
"The aim of this study is to report on Aminoglutethimide-induced hormonal modifications in advanced breast cancer."3.67Preliminary study of hormone determinations during aminoglutethimide therapy for advanced breast cancer. ( Díaz, L; Koliren, L; Loruso, A; Ramos, G; Scaglia, HE; Soto, E; Zylbersztein, C, 1984)
"Thirteen of 15 patients with malignant ascites achieved an excellent response to spironolactone, with an increase in urinary sodium excretion rates from less than 35 mEq/d before treatment to between 50 and 245 mEq/d after treatment."3.66Control of malignant ascites with spironolactone. ( Greenway, B; Johnson, PJ; Williams, R, 1982)
"Letrozole appears to be a very promising new antiaromatase drug."2.68Letrozole, a new oral non-steroidal aromastase inhibitor in treating postmenopausal patients with advanced breast cancer. A pilot study. ( Bisagni, G; Cocconi, G; Fraschini, F; Pfister, C; Scaglione, F; Trunet, PF, 1996)
" While this regimen effectively blocked adrenal function, it was complicated by a drug interaction in which aminoglutethimide accelerated the metabolism and reduced the bioavailability of dexamethasone."2.36Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer. ( Harvey, H; Kendall, J; Lipton, A; Ruby, EB; Samojlik, E; Santen, RJ; Wells, SA, 1977)
"A subgroup of ERα-positive breast cancer is characterized by mosaic presence of a minor population of ERα-negative cancer cells expressing the basal cytokeratin-5 (CK5)."1.43Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism. ( Girondo, MA; Goodman, CR; Hooke, JA; Hyslop, T; Kovatich, AJ; Liu, C; Mitchell, EP; Peck, AR; Rui, H; Sato, T; Shriver, CD; Yanac, AF; Yang, N, 2016)
"Aldosterone levels were significantly lowered below pretreatment values by the 1- and 2-mg twice daily doses."1.28Preliminary study of the treatment of advanced breast cancer in postmenopausal women with the aromatase inhibitor CGS 16949A. ( Coombes, RC; Davenport, J; Dowsett, M; Ford, HT; Gazet, JC; Hedley, A; Stein, RC, 1990)

Research

Studies (42)

TimeframeStudies, this research(%)All Research%
pre-199024 (57.14)18.7374
1990's10 (23.81)18.2507
2000's5 (11.90)29.6817
2010's2 (4.76)24.3611
2020's1 (2.38)2.80

Authors

AuthorsStudies
Nounu, A1
Kar, SP1
Relton, CL1
Richmond, RC1
Goodman, CR1
Sato, T1
Peck, AR1
Girondo, MA1
Yang, N1
Liu, C1
Yanac, AF1
Kovatich, AJ1
Hooke, JA1
Shriver, CD1
Mitchell, EP1
Hyslop, T1
Rui, H1
Rigiracciolo, DC1
Scarpelli, A1
Lappano, R1
Pisano, A1
Santolla, MF1
Avino, S1
De Marco, P1
Bussolati, B1
Maggiolini, M1
De Francesco, EM1
RIGHI, V1
RIVERA, EM1
ELIAS, JJ1
BERN, HA1
NAPALKOV, NP1
PITELKA, DR1
RIVADENEYRA, J1
ABBES, M1
CAMBON, P1
PAILLAUD, F1
Leo, JC1
Guo, C1
Woon, CT1
Aw, SE1
Lin, VC1
Honda, M1
Tsukada, T1
Horiuchi, T1
Tanaka, R1
Yamaguchi, K1
Obara, T1
Miyakawa, H1
Yamaji, T1
Ishibashi, M1
Halberg, F3
Scaglia, HE1
Koliren, L1
Loruso, A1
Zylbersztein, C1
Ramos, G1
Díaz, L1
Soto, E1
Sheeler, LR1
Myers, JH1
Eversman, JJ1
Taylor, HC1
Nelson, W1
Bingham, C1
Haus, E2
Lakatua, DJ1
Kawasaki, T1
Worgul, TJ1
Santen, RJ7
Samojlik, E2
Wells, SA3
Hermida Domínguez, RC1
del Pozo, F1
Greenway, B1
Johnson, PJ1
Williams, R1
Sebastian, A1
Sutton, JM1
Hulter, HN1
Schambelan, M1
Poler, SM1
Plourde, PV1
Dyroff, M1
Dowsett, M2
Demers, L1
Yates, R1
Webster, A1
Carella, MJ1
Dimitrov, NV1
Gossain, VV1
Srivastava, L1
Rovner, DR1
Demers, LM4
Lipton, A6
Harvey, HA3
Hanagan, J2
Mulagha, M2
Kambic, KB1
Grossberg, H1
Brady, C1
Bisagni, G1
Cocconi, G1
Scaglione, F1
Fraschini, F1
Pfister, C1
Trunet, PF1
Goss, PE1
Clark, RM1
Ambus, U1
Weizel, HA1
Wadden, NA1
Crump, M1
Walde, D1
Tye, LM1
De Coster, R1
Bruynseels, J1
Rosenberg Zand, RS1
Jenkins, DJ1
Diamandis, EP1
Bello-Reuss, E1
Ernest, S1
Holland, OB1
Hellmich, MR1
Tominaga, T1
Kimura, M1
Toge, T1
Takashima, S1
Nomura, Y1
Ohashi, Y1
Blankvoort, BM1
de Groene, EM1
van Meeteren-Kreikamp, AP1
Witkamp, RF1
Rodenburg, RJ1
Aarts, JM1
Harvey, H3
Ruby, EB1
Kendall, J1
Honn, KV1
Chavin, W1
Braley, LM1
Williams, GH1
Haagensen, DE1
Ruby, EJ1
Dilley, WG1
Lynch, J1
Garber, JE1
Henderson, IC1
Navari, RM1
Stein, RC1
Davenport, J1
Hedley, A1
Ford, HT1
Gazet, JC1
Coombes, RC1
Melby, JC2
Wilson, TE1
Wander, HE1
Blossey, HC1
Nagel, GA1
Emrich, D1
Matsuda, M1
Plata, EJ1
Aoki, T1
Robertson, DD1
Chu, EW1
Gerwin, BI1
Wellings, SR1
Jentoft, VL1
Grekin, RJ1
Dale, SL1
Givens, JR1
Camacho, A1
Patterson, P1
Ceriani, RL1
Contesso, GP1
Nataf, BM1
De Nicola, AF1
Traikov, H1
Birmingham, MK1
Palmer, JD1
Ruddick, DW1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
PHASE III RANDOMIZED CONTROL CASE STUDY OF LETROZOLE IN WOMEN WITH HEAVILY PRETREATED OVARIAN CANCER (MITO 32)[NCT04421547]Phase 3236 participants (Anticipated)Interventional2020-06-01Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

4 reviews available for aldosterone and Breast Neoplasms

ArticleYear
Quo vadis basic and clinical chronobiology: promise for health maintenance.
    The American journal of anatomy, 1983, Volume: 168, Issue:4

    Topics: Adrenal Cortex; Alcoholism; Aldosterone; Biological Clocks; Blood Pressure; Breast Neoplasms; Cardio

1983
Toward chronobiologic pattern discrimination of the risk of developing breast cancer and other diseases.
    Revista espanola de oncologia, 1982, Volume: 29, Issue:2

    Topics: Adolescent; Adult; Age Factors; Aldosterone; Breast Neoplasms; Carbohydrate Metabolism; Circadian Rh

1982
ARIMIDEX: a new oral, once-a-day aromatase inhibitor.
    The Journal of steroid biochemistry and molecular biology, 1995, Volume: 53, Issue:1-6

    Topics: Administration, Oral; Aldosterone; Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Drug Adminis

1995
Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer.
    Cancer, 1977, Volume: 39, Issue:6 Suppl

    Topics: Adrenocorticotropic Hormone; Aldosterone; Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehy

1977

Trials

9 trials available for aldosterone and Breast Neoplasms

ArticleYear
ARIMIDEX: a new oral, once-a-day aromatase inhibitor.
    The Journal of steroid biochemistry and molecular biology, 1995, Volume: 53, Issue:1-6

    Topics: Administration, Oral; Aldosterone; Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Drug Adminis

1995
Adrenal effects of low-dose aminoglutethimide when used alone in postmenopausal women with advanced breast cancer.
    Metabolism: clinical and experimental, 1994, Volume: 43, Issue:6

    Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Aged; Aldosterone; Aminoglutethimide; Breast Neoplasms

1994
The effects of long term fadrozole hydrochloride treatment in patients with advanced stage breast cancer.
    The Journal of steroid biochemistry and molecular biology, 1993, Volume: 44, Issue:4-6

    Topics: Adrenocorticotropic Hormone; Aldosterone; Breast Neoplasms; Estradiol; Estrone; Fadrozole; Female; H

1993
The efficacy of CGS 20267 in suppressing estrogen biosynthesis in patients with advanced stage breast cancer.
    The Journal of steroid biochemistry and molecular biology, 1993, Volume: 44, Issue:4-6

    Topics: Aldosterone; Anti-Inflammatory Agents, Non-Steroidal; Aromatase Inhibitors; Breast Neoplasms; Cosynt

1993
Letrozole, a new oral non-steroidal aromastase inhibitor in treating postmenopausal patients with advanced breast cancer. A pilot study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1996, Volume: 7, Issue:1

    Topics: Adult; Aged; Aldosterone; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhi

1996
Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1995, Volume: 1, Issue:3

    Topics: Aged; Aged, 80 and over; Aldosterone; Androgens; Antineoplastic Agents; Aromatase Inhibitors; Breast

1995
[A combined effect of fadrozole and tamoxifen in postmenopausal patients with recurrent breast cancer: a preliminary report: Japanese Cooperative Study Group of Fadrozole and Tamoxifen].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:11

    Topics: Aged; Aldosterone; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols;

2000
[Megestrol acetate in various doses in the treatment of metastatic breast carcinoma--clinical and endocrinologic studies].
    Klinische Wochenschrift, 1985, Apr-01, Volume: 63, Issue:7

    Topics: Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Breast Neoplasms; Female; Humans; Hydrocortis

1985
Effect of aminoglutethimide and reserpine on the human pituitary-adrenal axis: remission of a case of Cushing's disease.
    Metabolism: clinical and experimental, 1970, Volume: 19, Issue:10

    Topics: 17-Hydroxycorticosteroids; Addison Disease; Adrenal Glands; Adult; Aldosterone; Aminoglutethimide; A

1970

Other Studies

30 other studies available for aldosterone and Breast Neoplasms

ArticleYear
Sex steroid hormones and risk of breast cancer: a two-sample Mendelian randomization study.
    Breast cancer research : BCR, 2022, 10-08, Volume: 24, Issue:1

    Topics: 17-alpha-Hydroxyprogesterone; Adult; Aldosterone; Androstenedione; Breast Neoplasms; Dehydroepiandro

2022
Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism.
    Oncogene, 2016, Mar-17, Volume: 35, Issue:11

    Topics: Aldosterone; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation;

2016
GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells.
    Oncotarget, 2016, Jan-05, Volume: 7, Issue:1

    Topics: Aldosterone; Breast Neoplasms; Cation Transport Proteins; Cell Line, Tumor; Cell Movement; Cell Prol

2016
[Study of adrenocortical function in patients subjected to mastectomy for breast cancer and treated by preoperative roentgenotherapy].
    Rivista di patologia e clinica, 1962, Volume: 17

    Topics: Adrenal Cortex; Adrenal Cortex Hormones; Aldosterone; Breast Neoplasms; Humans; Mastectomy; Radiothe

1962
TOXIC EFFECTS OF STERIOD HORMONES ON ORGAN CULTURES OF MOUSE MAMMARY TUMORS, WITH A COMMENT ON THE OCCURRENCE OF VIRAL INCLUSION BODIES.
    Journal of the National Cancer Institute, 1963, Volume: 31

    Topics: Adenocarcinoma; Alcohols; Aldosterone; Animals; Breast Neoplasms; Cholesterol; Corticosterone; Desox

1963
[INVESTIGATION OF THE BIOLOGICAL ACTIVITIES OF TRIAMCINOLONE DIACETATE IN PATIENTS WITH ADRENAL INSUFFICIENCY].
    Revista medica del Hospital General, 1964, Volume: 27

    Topics: Adrenal Cortex Hormones; Adrenal Insufficiency; Adrenalectomy; Aldosterone; Blood; Blood Pressure; B

1964
[APPLICATION OF ANTI-ALDOSTERONE DIURETICS TO THE TREATMENT OF LOCALIZED EDEMA OF THE EXTREMITIES IN CANCER PATIENTS].
    La Presse medicale, 1965, May-01, Volume: 73

    Topics: Aldosterone; Breast Neoplasms; Diuretics; Edema; Extremities; Female; Humans; Mastectomy; Mineraloco

1965
Glucocorticoid and mineralocorticoid cross-talk with progesterone receptor to induce focal adhesion and growth inhibition in breast cancer cells.
    Endocrinology, 2004, Volume: 145, Issue:3

    Topics: Aldosterone; Breast Neoplasms; Cell Division; Cell Line, Tumor; Dexamethasone; Female; Focal Adhesio

2004
Primary hyperparathyroidism associatiated with aldosterone-producing adrenocortical adenoma and breast cancer: relation to MEN1 gene.
    Internal medicine (Tokyo, Japan), 2004, Volume: 43, Issue:4

    Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Breast Neoplasms; DNA

2004
Preliminary study of hormone determinations during aminoglutethimide therapy for advanced breast cancer.
    European journal of gynaecological oncology, 1984, Volume: 5, Issue:3

    Topics: Adult; Aged; Aldosterone; Aminoglutethimide; Bone Neoplasms; Breast Neoplasms; Dehydroepiandrosteron

1984
Adrenal insufficiency secondary to carcinoma metastatic to the adrenal gland.
    Cancer, 1983, Oct-01, Volume: 52, Issue:7

    Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenal Insufficiency; Adrenocort

1983
Rhythm-adjusted age effects in a concomitant study of twelve hormones in blood plasma of women.
    Journal of gerontology, 1980, Volume: 35, Issue:4

    Topics: Adolescent; Adult; Age Factors; Aldosterone; Analysis of Variance; Breast Neoplasms; Circadian Rhyth

1980
How effective is surgical adrenalectomy in lowering steroid hormone concentrations?
    The Journal of clinical endocrinology and metabolism, 1982, Volume: 54, Issue:1

    Topics: Adrenalectomy; Aged; Aldosterone; Androgens; Androstenedione; Breast Neoplasms; Dehydroepiandrostero

1982
Control of malignant ascites with spironolactone.
    The British journal of surgery, 1982, Volume: 69, Issue:8

    Topics: Abdominal Neoplasms; Aldosterone; Ascites; Breast Neoplasms; Female; Humans; Male; Renin; Sodium; Sp

1982
Effect of mineralocorticoid replacement therapy on renal acid-base homeostasis in adrenalectomized patients.
    Kidney international, 1980, Volume: 18, Issue:6

    Topics: Acid-Base Equilibrium; Adrenal Glands; Adrenalectomy; Aldosterone; Breast Neoplasms; Cushing Syndrom

1980
Development and evaluation of a competitive time-resolved immunofluorometric assay for the estrogen-regulated protein pS2.
    Journal of clinical laboratory analysis, 1999, Volume: 13, Issue:5

    Topics: Aldosterone; Amino Acid Sequence; Antibodies, Monoclonal; Binding, Competitive; Biotin; Breast Neopl

1999
Role of multidrug resistance P-glycoprotein in the secretion of aldosterone by human adrenal NCI-H295 cells.
    American journal of physiology. Cell physiology, 2000, Volume: 278, Issue:6

    Topics: Adrenal Glands; Aldosterone; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplas

2000
Development of an androgen reporter gene assay (AR-LUX) utilizing a human cell line with an endogenously regulated androgen receptor.
    Analytical biochemistry, 2001, Nov-01, Volume: 298, Issue:1

    Topics: Aldosterone; Androgens; Breast Neoplasms; Dexamethasone; Down-Regulation; Estradiol; Genes, Regulato

2001
In vitro effects of theophylline and aminogluthetimide upon basal and ACTH induced cAMP levels and steroid output by the normal human adrenal gland.
    Acta endocrinologica, 1978, Volume: 88, Issue:2

    Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Aminoglutethimide; Breast Neoplasms; Cycli

1978
The effect of angiotensin II and saralasin on 18-hydroxy-11-deoxycorticosterone production by isolated human adrenal glomerulosa cells.
    The Journal of clinical endocrinology and metabolism, 1979, Volume: 49, Issue:4

    Topics: 18-Hydroxycorticosterone; 18-Hydroxydesoxycorticosterone; Adrenal Glands; Adrenalectomy; Aldosterone

1979
Medical adrenalectomy with aminoglutethimide: clinical studies in postmenopausal patients with metastatic breast carcinoma.
    Annals of surgery, 1978, Volume: 187, Issue:5

    Topics: Adrenal Cortex; Adrenalectomy; Aldosterone; Aminoglutethimide; Androstenedione; Bone Neoplasms; Brea

1978
Specificity of low dose fadrozole hydrochloride (CGS 16949A) as an aromatase inhibitor.
    The Journal of clinical endocrinology and metabolism, 1991, Volume: 73, Issue:1

    Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Aldosterone; Androstenedione; Aromatase I

1991
Preliminary study of the treatment of advanced breast cancer in postmenopausal women with the aromatase inhibitor CGS 16949A.
    Cancer research, 1990, Mar-01, Volume: 50, Issue:5

    Topics: Aldosterone; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Drug Evaluation; Electro

1990
The effects of CGS 16949A, an aromatase inhibitor on adrenal mineralocorticoid biosynthesis.
    The Journal of clinical endocrinology and metabolism, 1990, Volume: 70, Issue:4

    Topics: 18-Hydroxycorticosterone; Adrenal Cortex; Adrenocorticotropic Hormone; Aged; Aldosterone; Aromatase

1990
Autotransplantation of the adrenal gland using microvascular anastomosis.
    Transplantation proceedings, 1987, Volume: 19, Issue:1 Pt 3

    Topics: 17-Hydroxycorticosteroids; Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Aldost

1987
An established cultured cell line (HBT-39) from human breast carcinoma.
    Journal of the National Cancer Institute, 1973, Volume: 50, Issue:4

    Topics: Adult; Aldosterone; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cell Division; Cell L

1973
Organ cultures of normal, dysplastic, hyperplastic, and neoplastic human mammary tissues.
    Journal of the National Cancer Institute, 1972, Volume: 49, Issue:2

    Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Scirrhous; Adenofibroma; Aldosterone; Biopsy; Breast Disea

1972
The role of 18-hydroxy-11-deoxycorticosterone as a precursor in human adrenal tissue in vitro.
    The Journal of clinical endocrinology and metabolism, 1973, Volume: 37, Issue:2

    Topics: Adrenal Glands; Adult; Aldosterone; Breast Neoplasms; Carbon Isotopes; Humans; Hydroxycorticosteroid

1973
Hormone requirement for growth and differentiation of the human mammary gland in organ culture.
    Cancer research, 1972, Volume: 32, Issue:10

    Topics: Adenofibroma; Aldosterone; Breast; Breast Neoplasms; Cell Differentiation; Culture Media; Epithelial

1972
18-hydroxylation by human adrenal tissue in vitro.
    The Journal of clinical endocrinology and metabolism, 1970, Volume: 30, Issue:3

    Topics: Adrenal Glands; Aldosterone; Breast Neoplasms; Carbon Isotopes; Corticosterone; Crystallization; Des

1970